West Paces Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1
Closed -$390 – 735
2026
Q2
$390 Buy
+1
New +$423 ﹤0.01% 714
2024
Q1
– Sell
-4
Closed -$1.08K – 625
2023
Q4
$1.08K Buy
+4
New +$989 ﹤0.01% 502
2023
Q3
– Sell
-58
Closed -$17.6K – 544
2023
Q2
$17.6K Hold
58
– – 0.01% 322
2023
Q1
$15.3K Hold
58
– – ﹤0.01% 332
2022
Q4
$13.9K Buy
+58
New +$13K ﹤0.01% 323
2022
Q3
– Sell
-13
Closed -$2.59K – 543
2022
Q2
$2.18K Sell
13
-12
-48% -$2.58K ﹤0.01% 486
2022
Q1
$6.27K Hold
25
– – ﹤0.01% 395
2021
Q4
$6.42K Buy
25
+13
+108% +$3.18K ﹤0.01% 407
2021
Q3
$2.91K Hold
12
– – ﹤0.01% 467
2021
Q2
$2.48K Buy
+12
New +$2.45K ﹤0.01% 507
2017
Q3
– Sell
-47
Closed -$4.1K – 487
2017
Q2
$4.1K Hold
47
– – ﹤0.01% 402
2017
Q1
$4.18K Buy
47
+21
+81% +$1.75K ﹤0.01% 398
2016
Q4
$1.92K Buy
+26
New +$1.95K ﹤0.01% 488

Other funds holding HCA

West Paces Advisors's HCA Position: Q3 2026 in Review

West Paces Advisors sold out of HCA Healthcare (HCA) in Q3 2026, closing a stake of 1 share — an estimated $390 sold.

West Paces Advisors first reported a position in HCA in Q4 2016 and held it in 13 quarters. The position peaked at $17.6K in Q2 2023. 584 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • West Paces Advisors reported no remaining HCA Healthcare position as of Q3 2026 after selling out during the quarter.
  • West Paces Advisors sold 1 HCA Healthcare share in Q3 2026, an estimated $390.
  • West Paces Advisors first reported a position in HCA Healthcare in Q4 2016 and held it in 13 quarters.
  • West Paces Advisors's HCA Healthcare position peaked at $17.6K in Q2 2023.
  • 584 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.